LONDON, GREATER LONDON, UK, November 14, 2018 /EINPresswire.com/ — In North America, which accounts for over 30% of the global market, sales of drugs to treat or prevent infectious diseases are falling at 0.1% year on year, as Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 from The Business Research Company shows. Another large market, Western Europe, is also growing slowly, at a meagre 2.7% annually. Sales in South America and Africa are booming, rising at an annual 8.8% and 6.8% respectively, but these are small markets. The only substantial high growth market region for anti-infective drugs is Asia Pacific, accounting for 20% of the global total and growing at 6.8% a year. Thus, Asia Pacific is the region that presents the best opportunities for manufacturers of anti-infective drugs, although competition in the region is fierce: sales of low-priced generic versions of out-of-patent drugs are highly significant.
The global growth of the anti-infective drugs market, held back by the slow rise in the largest regions, is around 3% a year.
Infectious diseases are disorders caused by pathogenic organisms such as bacteria, viruses, fungi or parasites. These diseases can be transmitted or spread from one person to another through direct or indirect contact. Anti-infective drugs are used to treat or prevent these infectious diseases by inhibiting the spread of an infectious agent (static) or by killing the infectious agent (cidal). The main anti-infective drugs include antibiotics, antifungals, antimalarial agents, antituberculosis agents, antiviral agents, penicillins, sulfonamides and tetracyclines.
In the developed world, the incidence of the major kinds of lethal infectious illness has substantially reduced despite periodic viral epidemics such as 'flu and the recent return of tuberculosis affecting small numbers of patients. The low incidence helps explain the low rate of growth of the anti-infective drugs market in North America and Western Europe and why the opportunities for anti-infective drugs manufacturers there are limited. In the less developed world, fatal diseases such as malaria still have high prevalence, while climatic conditions encourage fungal and bacterial illness. This helps account for the high growth rates for anti-infective drugs in South America, Africa and Asia Pacific.
Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 is one of a series of new industry reports from The Business Research Company that identify opportunities and explain strategies in over 300 markets, covering over 2400 market segments and 56 geographies. It provides a pharmaceutical industry overview, pharmaceutical industry analysis, past drug industry statistics and forecasts. Like the other reports in the series it also provides market growth rates, market trends, market drivers, market restraints, market revenues, market shares and company profiles of the leading competitors. These industry reports draw on 150,000 datasets. Extensive secondary research is augmented with exclusive insights and quotations from industry leaders obtained through interviews. Market analysis and forecasts are provided by a highly experienced and expert team of analysts and modelers. Strategies for the pharmaceutical drugs market are explained and key opportunities identified.
Where To Learn More
Read the Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021 from The Business Research Company for more information on the following:
Markets Covered: Pharmaceutical drugs, healthcare market, musculoskeletal disorders drugs, cardiovascular drugs, oncology drugs, anti-infective drugs, metabolic disorders drugs, central nervous system drugs, genito-urinary drugs, respiratory diseases drugs, gastrointestinal drugs, hematology drugs, dermatology drugs, ophthalmology drugs
Pharmaceutical Drugs Market Companies Covered: Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd., Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, GlaxoSmithKline Plc., Bayer AG, Teva Pharmaceuticals, Merck & Co.
Regions: North America, Asia Pacific, Western Europe, South America, Eastern Europe, Middle East, Africa.
Countries: USA, China, UK, Japan, France, Germany, Australia, India, Spain, Russia, Italy, Brazil
Time Series: Five years historic (2013-17) and forecast (2017-21).
Data Segmentations: Pharmaceutical drugs market size, historic and forecast size and growth rates for the world, 7 regions and 12 countries, pharmaceutical drugs market split by segments (musculoskeletal disorders drugs, cardiovascular drugs, oncology drugs, anti-infective drugs, metabolic disorders drugs, central nervous system drugs, genito-urinary drugs, respiratory diseases drugs, gastrointestinal drugs, hematology drugs, dermatology drugs, ophthalmology drugs) historic and forecast size, segment shares, and growth rates for the world, 7 regions and 12 countries, global competitor sales and market shares.
Healthcare market segment shares for the world, 7 regions and 12 countries.
Other Data: Per capita average pharmaceutical drugs expenditure and pharmaceutical drugs market size as a percentage of GDP, global and by country; number of general practitioners, average pharmaceutical drugs revenue per general practitioner, number of pharmacies per 100,000 population, number of pharmacists, average pharmaceutical drugs revenue per pharmacist, number of employees in pharmaceutical industry, average revenue per pharmaceutical employee, number of pharmaceutical enterprises, average pharmaceutical drugs revenue per pharmaceutical enterprise, generic & branded sales proportion by country (value), and new drug approvals- 2017, by country.
Other Information: Drivers and restraints of the global pharmaceutical drugs market, PESTEL analysis, pharmaceutical drugs market customer information, company profiles including products, strategy and financial performance for 5 pharmaceutical drugs companies, pharmaceutical drugs market trends and strategies, pharmaceutical drugs market key mergers and acquisitions
Strategies For Participants In The Pharmaceutical Industry: Over 25 strategies based in key trends and company reports, including developing enzyme replacement therapies for the treatment of rare metabolic disorders and responding to the growing demand for tamper-resistant pseudoephedrine (pse) products.
Key Opportunities In The Pharmaceutical Market: The report identifies the subsegments by country and condition or therapy that represent the best opportunities to 2022.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes. Sources include primary as well as extensive secondary research.
Number of Figures in the report: 151
Number of Tables in the report: 151
Interested to know more? Here is a list of reports similar to “Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021”:
Anti-Infective Drugs Global Market Report 2018(https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-global-market-report-2018)
Cardiovascular Drugs Global Market Report 2018(https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2018)
Central Nervous System Drugs Global Market Report 2018(https://www.thebusinessresearchcompany.com/report/central-nervous-system-drugs-global-market-report-2018)
Dermatology Drugs Global Market Report 2018(https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018)
Gastrointestinal Drugs Global Market Report 2018(https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2018)
Source: EIN Presswire